Quince Therapeutics files 8-K on director changes
Quince Therapeutics said several directors resigned from its board and named four new directors effective Oct. 8, 2026. The filing also disclosed compensation terms for Keith R. Fandrick.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
3 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Genie Energy Q2 2026 Earnings Call Transcript
On Thursday, Genie Energy (NYSE: GNE ) discussed second-quarter financial results during its earnings call. The full transcript is provided below. APIs provide real-time access to earnings call transcripts and financial data. Visit to learn more. View the webcast at Summary Genie Energy Limited reported a 4.6% decrease
Hop-on files patent
Hop-on subsidiary develops digital licensing system, files patent application. Potential impact on intellectual property management.